
- Volume 0 0
Consumer Fraud Mars Medicare Rx Program
While pharmacists across the countrywere working to help seniors understandtheir benefits under the newMedicare prescription drug program,health care hucksters were finding creativeways to use the program todefraud consumers and the government.Among the more disturbingpractices uncovered by the Centers forMedicare and Medicaid Services (CMS):bogus prescription plan sponsors whoare using the new Medicare benefit as aruse to engage in identity theft.
With the January 1, 2006, deadlinefor implementing the new benefitlooming, federal Medicare officialsannounced a campaign to "fight fraudand abuse and help people withMedicare protect themselves" fromscammers. As part of that effort, CMS isusing outside "Rx Integrity Contractors"to investigate potentially fraudulentactivity in connection with thenew program, and pharmacists arebeing urged to help seniors protectthemselves against these fraudulentpractices.
In calling on Medicare beneficiariesto consult with their pharmacists concerningthe new program, officials atthe American Pharmacists Associationsaid, "The nation's pharmacists areready to help protect their patientsfrom phony marketers and unscrupulousoperators."
Mr. Rankin is a freelance medical writer.
Articles in this issue
almost 20 years ago
CAN YOU READ THESE Rxs?almost 20 years ago
Bar Coding Thwarts Illegitimate Drug Usealmost 20 years ago
COMPREHENSIVE CARE CLINIC: DIABETES: Diabetes-related Stress and Depressionalmost 20 years ago
Hypertension Counseling Requires a Multifactorial Approachalmost 20 years ago
COMPOUNDING HOTLINEalmost 20 years ago
Pharmacy Law: Duty to Warn Waived When Patient Refuses Counselingalmost 20 years ago
EnterpriseRx Pharmacy Management Systemalmost 20 years ago
Hospital Installs Automated Medication Cabinetsalmost 20 years ago
"Smartphones" Help with Clinical Trial Informationalmost 20 years ago
HIT Needs Medicare's LeadershipNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.